Oragenics
OGEN
8 hedge funds and large institutions have $24.5M invested in Oragenics in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
21% more capital invested
Capital invested by funds: $20.2M → $24.5M (+$4.23M)
14% more funds holding
Funds holding: 7 → 8 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$163K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$122K |
| 3 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$81.5K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$81.5K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$40.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EEG
E.E. Geduld
|
-$34K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TS
1
Third Security
Radford,
Virginia
| $16.1M | – | – | – |
|
2
Fidelity Investments
Boston,
Massachusetts
| $4.5M | – | – | – |
|
|
MP
3
MSD Partners
New York
| $2.83M | – | – | – |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $528K | +$163K | +4 | +29% |
|
|
5
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| $213K | +$81.5K | +2 | +40% |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| $144K | +$122K | +3 | +150% |
|
|
VKH
7
Virtu KCG Holdings
New York
| $53K | +$81.5K | +2 | New |
|
|
8
Northern Trust
Chicago,
Illinois
| $39K | +$40.7K | +1 | New |
|
9
Walleye Trading
New York
| $7K | – | – | – |
|
10
UBS Group
Zurich,
Switzerland
| $6K | – | – | – |
|
11
Bank of America
Charlotte,
North Carolina
| $3K | – | – | – |
|
12
Citigroup
New York
| $1K | – | – | – |
|
13
Morgan Stanley
New York
| $1K | – | – | – |
|
|
EEG
14
E.E. Geduld
| – | -$34K | -1 | Closed |
|
OGEN Hedge Fund Activity: Q3 2015 in Review
8 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q3 2015, worth a combined $24.5M — up 21% from $20.2M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new OGEN positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, adding an estimated $163K. The largest seller was E.E. Geduld, exiting entirely with an estimated $34K sold.
- 8 institutional investors held Oragenics (OGEN) as of Q3 2015, up from 7 in Q2 2015.
- Funds reported $24.5M of Oragenics stock for Q3 2015, up 21% quarter-over-quarter.
- 2 funds opened new Oragenics positions in Q3 2015 and 1 closed out, a net change of +1 holder.
- The largest Oragenics buyer in Q3 2015 was Vanguard Group, an estimated $163K added.
- The largest Oragenics seller in Q3 2015 was E.E. Geduld, an estimated $34K sold.
Based on aggregated 13F filings for Q3 2015.